Screening Echocardiogram in High-Risk Women with Class III Obesity to Predict the Risk of Preeclampsia

Abstract

Objective Women with obesity and other comorbidities such as hypertension and diabetes are at an increased risk of preeclampsia and perinatal morbidity. This study evaluates whether screening echocardiogram can identify women with obesity at a higher risk of preeclampsia.

Methods We conducted a retrospective cohort study of women with class III obesity (body mass index [BMI] ≥40 kg/m²) and one or more medical comorbidities associated with an increased risk of preeclampsia (such as diabetes, hypertension, and rheumatologic disease) undergoing screening echocardiogram. Abnormal findings were defined as the presence of one or more of the following: diastolic dysfunction, ejection fraction of ≤45%, or cardiac chamber enlargement or hypertrophy. Multivariable logistic regression was used to estimate the odds ratio (OR) of gestational hypertension/mild preeclampsia, severe preeclampsia, and any preterm delivery <37 weeks associated with abnormal echocardiographic findings when controlling for potential confounders.

Results Of 267 eligible women, 174 (64%) underwent screening echocardiograms. Sixty-nine women (40%) had abnormal echocardiograms. Maternal clinical characteristics were similar between women with normal echocardiographic findings and women with abnormal findings. Women with abnormal echocardiograms were more likely to have chronic hypertension (78 vs. 62%, p = 0.04) and a history of preeclampsia (27 vs. 10%, p = 0.02). After controlling for confounders, women with abnormal echocardiogram were at an increased risk of hypertensive disorders of pregnancy, OR 6.80 (95% confidence interval [CI] 3.32–13.93, p = 0.01), and in particular severe preeclampsia, OR 8.77 (95% CI 3.90–19.74, p = 0.01).

Conclusion Among pregnant women with class III obesity and medical comorbidities, screening echocardiogram may help identify a subset of women at the highest risk of developing preeclampsia.

Key Points

• Women with obesity and comorbid conditions are at a high risk of abnormal echocardiogram.

• Women with obesity, medical comorbid conditions, and abnormal echo are at a high risk of preeclampsia.

• Screening echocardiogram can help identify obese women at the highest risk of severe preeclampsia.

Keywords

pregnancy - obesity - echocardiogram - hypertension - preeclampsia - maternal morbidity and mortality

Note

This research was presented as a poster at the American College of Obstetrics and Gynecology (ACOG) meeting in Nashville, TN 2019.

Publikationsverlauf

Eingereicht: 05. November 2020

Angenommen: 04. Oktober 2021

Artikel online veröffentlicht:
23. November 2021

• References

• 1 Meah VL, Cockcroft JR, Backx K, Shave R, Stöhr EJ. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart 2016; 102 (07) 518-526
• 2 Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014; 130 (12) 1003-1008
• 3 Desai DK, Moodley J, Naidoo DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol 2004; 104 (01) 20-29
• 4 Wierzbowska-Drabik K, Chrzanowski L, Kapusta A. et al. Severe obesity impairs systolic and diastolic heart function - the significance of pulsed tissue Doppler, strain, and strain rate parameters. Echocardiography 2013; 30 (08) 904-911
• 5 Dennis AT, Castro JM, Ong M, Carr C. Haemodynamics in obese pregnant women. Int J Obstet Anesth 2012; 21 (02) 129-134
• 6 Veille JC, Hanson R. Obesity, pregnancy, and left ventricular functioning during the third trimester. Am J Obstet Gynecol 1994; 171 (04) 980-983
• 7 Buddeberg BS, Sharma R, O'Driscoll JM, Kaelin Agten A, Khalil A, Thilaganathan B. Cardiac maladaptation in obese pregnant women at term. Ultrasound Obstet Gynecol 2019; 54 (03) 344-349
• 8 American College of Obstetricians and Gynecologists. ACOG Committee Opinion, no. 549: obesity in pregnancy. Obstet Gynecol 2012; 121: 213-217
• 9 Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation 2014; 130 (08) 703-714
• 10 Levine LD, Lewey J, Koelper N. et al. Persistent cardiac dysfunction on echocardiography in African American women with severe preeclampsia. Pregnancy Hypertens 2019; 17: 127-132
• 11 Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 2011; 58 (04) 709-715
• 12 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol 2019; 133 (01) e1-e25
• 13 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16 (03) 233-270
• 14 Redfield MM, Jacobsen SJ, Burnett Jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289 (02) 194-202
• 15 Lanier GM, Vaishnava P, Kosmas CE, Wagman G, Hiensch R, Vittorio TJ. An update on diastolic dysfunction. Cardiol Rev 2012; 20 (05) 230-236
• 16 Nagueh SF, Smiseth OA, Appleton CP. et al. Recommendations for the evaluation of left ventricular diastolic dysfunction by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016; 29 (04) 277-314